Inozyme Pharma News

Inozyme Pharma | 8-K: Current report

Apr 8 06:47 ET

Inozyme Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Treco Douglas A

Apr 3 17:30 ET

Inozyme Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Winton Matthew

Apr 3 17:26 ET

Inozyme Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Winton Matthew

Mar 15 08:35 ET

Inozyme Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Treco Douglas A

Mar 15 08:35 ET

Inozyme Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Subramanian Sanjay

Mar 15 08:35 ET

Inozyme Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 08:42 ET

Inozyme Pharma | 10-K: Annual report

Mar 12 08:37 ET

Inozyme Pharma | 8-K: Current report

Mar 12 08:37 ET

Inozyme Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sofinnova Venture Partners X, L.P. (“SVP X”)(6.9%),Sofinnova Management X, L.P. (“SM X LP”)(6.9%), etc.

Feb 20 19:14 ET

Inozyme Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(0.0%),VHCP Co-Investment Holdings II, LLC(0.0%), etc.

Feb 14 20:38 ET

Inozyme Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Feb 14 18:13 ET

Inozyme Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(0.0%),Baker Bros. Advisors (GP) LLC(0.0%), etc.

Feb 14 17:49 ET

Inozyme Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Samlyn Capital, LLC(5.5%),Samlyn, LP(5.5%), etc.

Feb 14 16:00 ET

Inozyme Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rock Springs Capital Management LP(5.96%),Rock Springs Capital LLC(5.96%), etc.

Feb 14 14:13 ET

Inozyme Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Eventide Asset Management, LLC(5.15%),Finny Kuruvilla, M.D. Ph. D.(5.15%), etc.

Feb 14 11:57 ET

Inozyme Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.

Feb 14 08:52 ET

Inozyme Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pivotal Partners Ltd(7.2%),Pivotal Life Sciences Holdings Limited(7.2%), etc.

Feb 12 21:10 ET

Inozyme Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(8.97%),Adage Capital Partners GP, L.L.C.(8.97%), etc.

Feb 7 07:50 ET

Inozyme Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sphera Funds Management Ltd.(2.53%),Sphera Global Healthcare GP Ltd.(2.53%), etc.

Feb 5 09:17 ET